Idiopathic Pulmonary Fibrosis clinical trials
Access comprehensive clinical trial information for Idiopathic Pulmonary Fibrosis through Pure Global AI's free database. This collection includes 305 clinical trials across multiple phases including N/A, Phase 2, Phase 1. Currently, 72 trials are actively recruiting participants.
Research for Idiopathic Pulmonary Fibrosis is being conducted in United States of America, China, United Kingdom and 7+ other countries. Leading sponsors include Boehringer Ingelheim and Hoffmann-La Roche. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.
Pure Global AI provides free access to 305 clinical trials studying Idiopathic Pulmonary Fibrosis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.
The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.
Top research sponsors include Boehringer Ingelheim, Hoffmann-La Roche, Royal Brompton & Harefield NHS Foundation Trust, among others.